XBI Stock Overview
SPDR Series Trust - SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
SPDR Series Trust - SPDR S&P Biotech ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$84.69 |
52 Week High | US$103.52 |
52 Week Low | US$63.80 |
Beta | 0 |
1 Month Change | -8.61% |
3 Month Change | -4.31% |
1 Year Change | 6.73% |
3 Year Change | -39.37% |
5 Year Change | 1.26% |
Change since IPO | 415.88% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
XBI | US Capital Markets | US Market | |
---|---|---|---|
7D | 0.05% | 3.0% | 1.2% |
1Y | 6.7% | 31.9% | 24.7% |
Return vs Industry: XBI underperformed the US Capital Markets industry which returned 23.2% over the past year.
Return vs Market: XBI underperformed the US Market which returned 19.3% over the past year.
Price Volatility
XBI volatility | |
---|---|
XBI Average Weekly Movement | 4.2% |
Capital Markets Industry Average Movement | 3.5% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: XBI has not had significant price volatility in the past 3 months.
Volatility Over Time: XBI's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | n/a | n/a | www.ssga.com/us/en/intermediary/etfs/funds/spdr-sp-biotech-etf-xbi?fundSeoName=spdr-sp-biotech-etf-XBI |
SPDR Series Trust - SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization.
SPDR Series Trust - SPDR S&P Biotech ETF Fundamentals Summary
XBI fundamental statistics | |
---|---|
Market cap | US$6.60b |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs XBI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
XBI income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did XBI perform over the long term?
See historical performance and comparison